1-5 of 5
Steven W. Elmore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Refractory or Relapsed Lymphoid Malignancies.

Wyndham H. Wilson, Anil Tulpule, Alexandra M. Levine, Kieron Dunleavy, Andrew P. Krivoshik, Anne E. Hagey, Margaret Shovlin, Melanie A. Gloria, Renee Greco, Hao Xiong, Yi-Lin Chiu, Steven W. Elmore, Owen A. O’Connor
Journal: Blood
Blood (2007) 110 (11): 1371.
https://doi.org/10.1182/blood.V110.11.1371.1371
Published: 2007
Journal Articles

The Bcl-2 Family Inhibitor ABT-263 Shows Significant but Reversible Thrombocytopenia in Mice.

Alex R. Shoemaker, PhD, Michael J. Mitten, B.S., Jessica Adickes, B.S., Anatol Oleksijew, B.S., Haichao Zhang, Ph.D., Joy Bauch, B.S., Kennan Marsh, Ph.D., David J. Frost, Ph.D., David Madar, Ph.D., Christin Tse, Ph.D., Stephen W. Fesik, Ph.D., Saul H. Rosenberg, Ph.D., Steven W. Elmore, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1107.
https://doi.org/10.1182/blood.V108.11.1107.1107
Published: 2006
Journal Articles

The Bcl-2 Family Protein Inhibitor, ABT-263, Promotes Apoptotic-Like Response in Isolated Platelets.

Chris Tse, PhD, Haichao Zhang, PhD, Jun Chen, PhD, Ryan M. Fryer, PhD, Richard Nelson, Paul Nimmer, Glenn A. Reinhart, PhD, Morey L. Smith, Stephen K. Tahir, PhD, Saul H. Rosenberg, PhD, Steven W. Elmore, PhD
Journal: Blood
Blood (2006) 108 (11): 1122.
https://doi.org/10.1182/blood.V108.11.1122.1122
Published: 2006
Journal Articles

Bcl-2 Family Protein Inhibitors Induce a Unique Thrombocytopenia In Vivo .

Steven W. Elmore, PhD, Joy Bauch, Ryan M. Fryer, PhD, Laurie Iciek, PhD, Kennan Marsh, PhD, Sherry J. Morgan, PhD, DVM, Richard Nelson, Glenn A. Reinhart, PhD, Morey L. Smith, Chris Tse, PhD, Saul H. Rosenberg, PhD
Journal: Blood
Blood (2006) 108 (11): 4236.
https://doi.org/10.1182/blood.V108.11.4236.4236
Published: 2006
Journal Articles

The Bcl-2 Family Inhibitor ABT-263 Shows Significant Anti-Tumor Efficacy in Models of B Cell Non-Hodgkin’s Lymphoma.

Alex R. Shoemaker, PhD, Michael J. Mitten, B.S., Anatol Oleksijew, B.S., Jacqeuline M. O’Connor, Baole Wang, M.D., Scott Ackler, Ph.D., Mary Joseph, Ph.D., Haichao Zhang, Ph.D., Paul Nimmer, B.S., Yu Xiao, B.S., Christin Tse, Ph.D., David J. Frost, Ph.D., Stephen W. Fesik, Ph.D., Saul H. Rosenberg, Ph.D., Steven W. Elmore, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 825.
https://doi.org/10.1182/blood.V108.11.825.825
Published: 2006